LAURA WALLACE: Open Payments
NPI 1265737753 · PILOT KNOB, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 19 payments from 11 companies in 2025. Trend: 2023 $39 · 2024 $351 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $85 |
| Novo Nordisk Inc | 2 | $80 |
| Alexion Pharmaceuticals, Inc. | 1 | $79 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| Amgen Inc. | 2 | $32 |
| Sandoz Inc. | 1 | $30 |
| UCB, Inc. | 1 | $20 |
| Globus Medical, Inc. | 1 | $20 |
Products named: TREMFYA, Ozempic, SPRAVATO, SAPHNELO, VRAYLAR, JUBBONTI, Bimzelx, Senza.
Industry payments across MO — which companies pay providers there.
